Luengo-Fernandez R, Leal J, Gray AM. UK research expenditure on dementia, heart disease, stroke and cancer: are levels of spending related to disease burden. Eur J Neurol. 2012;19:149–54.
Article
CAS
PubMed
Google Scholar
Stuss DT, Levine B. The dementias: nosological and clinical factors related to diagnosis. Brain Cogn. 1996;31:99–113.
Article
CAS
PubMed
Google Scholar
Dubois B, Feldman HH, Jacova C, Cummings JL, DeKosky ST, Barberger-Gateau P, et al. Revising the definition of Alzheimer's disease: a new lexicon. Lancet Neurol. 2010;9:1118–27.
Article
PubMed
Google Scholar
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed (DSM-5). Arlington, VA: American Psychiatric Publishing; 2013.
World Health Organization. ICD-10 International Statistical Classification of Diseases and Related Health Problems. 10th ed. New York: World Health Organization; 2008.
Google Scholar
Clark LA, Watson D, Reynold S. Diagnosis and classification of psychopathology challenges to the current system and future directions. Annu Rev Psychol. 1995;46:121–53.
Article
CAS
PubMed
Google Scholar
Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, et al. Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Ageing-Alzheimers Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7:280–92.
Article
PubMed Central
PubMed
Google Scholar
Chui HC, Zheng L, Reed BR, Vinters HV, Mack WJ. Vascular risk factors and Alzheimer's disease: are these risk factors for plaques and tangles or for concomitant vascular pathology that increases the likelihood of dementia? An evidence-based review. Alzheimer's Res Ther. 2012;4:1.
Google Scholar
Schneider JA, Arvanitakis Z, Bang W, Bennett DA. Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology. 2007;69:2197–204.
Article
PubMed
Google Scholar
Schneider JA, Arvanitakis Z, Leurgans SE, Bennett DA. The neuropathology of probable Alzheimer disease and mild cognitive impairment. Ann Neurol. 2009;66:200–8.
Article
PubMed Central
PubMed
Google Scholar
Sonnen JA, Santa Cruz K, Hemmy LS, Woltjer LS, Leverenz JB, Montine KS, et al. Ecology of aging human brain. Arch Neurol. 2011;68:1049–56.
Article
PubMed Central
PubMed
Google Scholar
Hernandez AV, Steyerberg EW, Habbema JDF. Covariate adjustment in randomised controlled trials with dichotomous outcomes increases statistical power and reduces sample size requirements. J Clin Epidemiol. 2004;57:454–60.
Article
PubMed
Google Scholar
Feldman A, Rizzuto D, Narasimhalu K, Dahl A, Johansson A, Gregorio M, et al. Validity of dementia diagnoses in two Swedish health registers. Alzheimers Dement. 2012;8:493.
Article
Google Scholar
Jackson TA, Wilson D, Sheehan B. Screening for dementia in general hospital inpatients: a systematic review and meta-analysis of available instruments. Age Ageing. 2013;42:689–95.
Article
PubMed
Google Scholar
Tombaugh TN, McIntyre NJ. The Mini-Mental State Examination: a comprehensive review. J Am Geriatr Soc. 1992;40:922–35.
CAS
PubMed
Google Scholar
Lees R, Fearon P, Harrison JK, Broomfield NM, Quinn TJ. Cognitive and mood assessment in stroke research: focused review of contemporary studies. Stroke. 2012;43:1678–80.
Article
PubMed
Google Scholar
Lees R, Broomfield N, Quinn TJ. Questionnaire assessment of usual practice in stroke cognitive assessment across Scottish Stroke Units. Disability Rehabil. 2014;36:339–43.
Article
Google Scholar
Ferris SH, Lucca U, Mohs R, Dubois B, Wesnes K, Erzigkeit H. Objective psychometric tests in clinical trials of dementia drugs. Alzheimer Dis Assoc Disord. 1997;11:34–8.
PubMed
Google Scholar
Quinn TJ, Fearon P, Noel-Storr AH, Young C, McShane R, Stott DJ. Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the diagnosis of dementia within community dwelling populations. Cochrane Database Syst Rev. 2014;4, CD010079.
PubMed
Google Scholar
Davis DHJ, Creavin ST, Noel-Storr AH, Quinn TJ, Smailagic N, Hyde C, et al. Neuropsychological tests for the diagnosis of Alzheimer’s disease dementia and other dementias: a generic protocol for cross-sectional and delayed-verification studies. Cochrane Database Syst Rev. 2013;CD010460.
US Food and Drug Administration. Alzheimer's disease: Developing Drugs for the Treatment of Early Stage Disease. Draft guidance. Silver Spring, MD: US Department of Health and Human Services FDA, Center for Drug Evaluation and Research; 2013
Ferris S. Report of the working group on clinical global measures. Position paper from the International Working group on Harmonization of Dementia Drug Guidelines. Alzheimer Dis Assoc Disord. 1997;11:8–18.
Article
Google Scholar
Bond J. Quality of life for people with dementia: approaches to the challenge of measurement. Ageing Soc. 1999;19:561–79.
Article
Google Scholar
McMurdo ME, Roberts H, Parker S, Wyatt N, May H, Goodman C, et al. Improving recruitment of older people to research through good practice. Age Ageing. 2011;40:659–65.
Article
PubMed
Google Scholar
Bird TD. Genetic aspects of Alzheimer’s disease. Genet Med. 2008;10:321–9.
Article
Google Scholar
Solomon A, Mangialasche F, Richard E, Andrieu S, Bennett DA, Brteler M, et al. Advances in the prevention of Alzheimer’s disease and dementia. J Internal Med. 2014;275:229–50.
Article
CAS
PubMed
Google Scholar
Van Dam D, De Deyn PP. Animal models in the drug discovery pipeline for Alzheimer’s disease. Br J Pharmacol. 2011;164:1285–300.
Article
PubMed Central
PubMed
Google Scholar
Van der Worp HB, Howells DW, Sena ES, Porritt MJ, Rewell S, O'Collins V, et al. Can animal models of disease reliably inform human studies? PLoS Med. 2010;7:e1000245.
Article
PubMed Central
PubMed
Google Scholar
Commenges D, Letenneur L, Joly P, Alioum A, Dartigues JF. Modelling age-specific risk: application to dementia. Stat Med. 1998;17:1973–88.
Article
CAS
PubMed
Google Scholar
Sliwinksi MJ, Hofer SM, Hall C, Bushke H, Lipton RB. Modelling memory decline in older adults. Psychol Ageing. 2003;18:658–71.
Article
Google Scholar
Henderson R, Diggle P, Dobson A. Joint modelling of longitudinal measurements and event time data. Biostatistics. 2000;1:465–80.
Article
CAS
PubMed
Google Scholar
Hall BC, Ying J, Kuo L, Sliwinsli M, Buschke H, Katz M, et al. Estimate of bivariate measurements having different change points, with application to cognitive ageing. Stat Med. 2001;20:3695–714.
Article
CAS
PubMed
Google Scholar
Van den Hout A, Muniz Terrera G, Matthews FE. Smooth random change point models. Stat Med. 2011;30:599–610.
Article
PubMed
Google Scholar
Duffy L, Gajree S, Langhorne P, Stott DJ, Quinn TJ. Reliability (inter-rater agreement) of the Barthel Index for assessment of stroke survivors: systematic review and meta-analysis. Stroke. 2013;44:462–8.
Article
PubMed
Google Scholar
Jelic V, Kivipelto M, Winblad B. Clinical trials in mild cognitive impairment. J Neurol Neurosurg Psychiatry. 2006;77:429–38.
Article
PubMed Central
CAS
PubMed
Google Scholar
Petersen RC. Mild cognitive impairment as a diagnostic entity. J Int Med. 2004;256:183–94.
Article
CAS
Google Scholar
McArthur KS, Johnson PC, Quinn TJ, Higgins P, Langhorne P, Walters MR, et al. Improving the efficiency of stroke trials: feasibility and efficacy of group adjudication of functional endpoints. Stroke. 2013;44:3422–8.
Article
PubMed
Google Scholar
Mitchell AJ, Shiri-Feshki M. Rate of progression of mild cognitive impairment to dementia: meta-analysis of 41 robust inception cohort studies. Acta Psychiatrica Scand. 2009;119:252–65.
Article
CAS
Google Scholar
Noel-Storr A, Flicker L, Ritchie CW, Nguyen GH, Gupta T, Wood P, et al. Systematic review of the body of evidence for the use of biomarkers in the diagnosis of dementia. Alzheimers Dement. 2013;9:e96–105.
Article
PubMed
Google Scholar
Ritchie C, Smailagic N, Noel-Storr AH, Takwoingi Y, Flicker L, Mason SE, et al. Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI). Cochrane Database Syst Rev. 2014;CD008782.
Richard E, Schmand B, Eikelenboom P, Westendorp RG, Van Gool WA. The Alzheimer myth and biomarker research in dementia. J Alzheimers Dis. 2012;31:S203–940.
PubMed
Google Scholar
Fleming TR, DeMets DL. Surrogate end points in clinical trials: are we being misled. Ann Int Med. 1996;125:605–13.
Article
CAS
PubMed
Google Scholar
Bloudek LM, Spackman DE, Blankenburg M, Sullivan SD. Review and meta-analysis of biomarkers and diagnostic imaging in Alzheimer’s disease. J Alzheimers Dis. 2011;26:627–45.
Article
CAS
PubMed
Google Scholar
Brayne C, Davis D. Making Alzheimer's and dementia research fit for populations. Lancet. 2012;380:1441–3.
Article
PubMed Central
PubMed
Google Scholar
Ritchie K, Carrière I, Ritchie CW, Dufouil C, Dartigues JF, Berr C, et al. Can we design population prevention programs to reduce dementia incidence? A simulation of the impact of removal of specific risk factors. BMJ. 2010;341:c3885.
Article
PubMed Central
CAS
PubMed
Google Scholar
Richard E, Andrieu S, Solomon A, Mangialasche F, Ahtiluoto S, van Charante EPM, et al. Methodological challenges in designing dementia prevention trials - the European Dementia Prevention Initiative (EDPI). J Neurol Sci. 2012;322:64–70.
Article
PubMed
Google Scholar
Ritchie CW, Wells K, Ritchie K. The PREVENT research programme - a novel research programme to identify and manage midlife risk for dementia: the conceptual framework. Int Rev Psychiatry. 2013;25:748–54.
Article
PubMed
Google Scholar
Lincoln P, Fenton K, Alessi C, Prince M, Brayne C, Wortmann M, et al. The Backfriars Consensus on brain health and dementia. Lancet. 2014;383:1805–6.
Article
PubMed
Google Scholar
Matthews FE, Arthur A, Barnes LE, Bond J, Jagger C, Robinson L, et al. A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: results of the Cognitive Function and Ageing Study I and II. Lancet. 2013;382:1405–12.
Article
PubMed Central
PubMed
Google Scholar
Dementias Platform UK. http://www.mrc.ac.uk/research/facilities/dementias-research-platform/.
About EMIF-Alzheimer's disease. http://www.emif.eu/emif-ad/about-emif-alzheimers-disease.
Ali M, Bath PM, Curram J, Davis SM, Diener HC, Donnan GA, et al. The virtual international stroke trials archive. Stroke. 2007;38:1905–10.
Article
PubMed
Google Scholar
Quinn TJ, Dawson J, Lees JS, Chang TP, Walters MR, Lees KR, et al. Time spent at home poststroke: 'home-time' a meaningful and robust outcome measure for stroke trials. Stroke. 2008;39:231–3.
Article
PubMed
Google Scholar
White L, Samll BJ, Petrovitch H. Recent clinic-pathological research on the causes of dementia in late life: update from the Honolulu-Asia aging study. J Geriatr Psychiatry Neurol. 2005;18:224–7.
Article
PubMed
Google Scholar
Vellas B, Sampaio C, Bateman R, Boxer A, Carrillo MC, Cummings J, et al. E.U./U.S. CTAD task force on Alzheimer’s trial populations. 2014. J Prevention Alzheimer’s Dis. 2014;1:110–6.
Google Scholar
Noel-Storr AH, McCleery JM, Richard E, Ritchie CW, Flicker L, Cullum S, et al. Reporting standards for studies of diagnostic test accuracy in Alzheimer’s disease and dementia: the STARDdem (STAndards for the Reporting of Diagnostic accuracy studies-dementia) initiative. Neurology. 2014;83:364–73.
Article
PubMed Central
PubMed
Google Scholar
McClearn GE, Johansson B, Berg S, Pedersen NL, Ahern F, Petrill SA, et al. Substantial genetic influence on cognitive abilities in twins 80 or more years old. Science. 1997;276:1560–3.
Article
CAS
PubMed
Google Scholar
Hall CB, Lipon RB, Sliwinski M, Stewart WF. A change point model for estimating the onset of cognitive decline in Alzheimer’s disease. Stat Med. 2000;19:1555–66.
Article
CAS
PubMed
Google Scholar